Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer.
Kang CH, Kim EY, Kim HR, Lee CO, Lee HK, Jeong HG, Choi SU, Yun CS, Hwang JY, Lee JY, Son YH, Ahn S, Lee BH, Jung H, Park CH.
Kang CH, et al.
Cancer Lett. 2016 May 1;374(2):272-8. doi: 10.1016/j.canlet.2016.02.009. Epub 2016 Feb 26.
Cancer Lett. 2016.
PMID: 26923554